![](/img/cover-not-exists.png)
E23DEBIRI and cetuximab (DEBIRITUX) as a secondline treatment for unresectable colorectal liver metastases (UCLM): results of a phase II trial exploring a new sequence
Fiorentini, G., Aliberti, C., Sarti, D., Coschiera, P., Tilli, M., Mulazzani, L., Giordani, P., Graziano, F., Marqués Gonzalez, A., García Marcos, R., Gómez Mugnoz, F., Cantore, M., Ricci, S., CatalanVolume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv340.23
Date:
October, 2015
File:
PDF, 34 KB
english, 2015